During the past decade, SE AOK Bor, Nemikortani es Boronkologiai Klinika conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SE AOK Bor, Nemikortani es Boronkologiai Klinika" are "Dermatitis, Atopic" (3 trials), "Basal Cell Carcinoma" (1 trials), "Dermatitis" (1 trials), "Eczema" (1 trials) and "Genetic Diseases, Inborn" (1 trials). Many other conditions were trialed in "SE AOK Bor, Nemikortani es Boronkologiai Klinika" in a lesser frequency.

Most popular intervention types in "SE AOK Bor, Nemikortani es Boronkologiai Klinika" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "SE AOK Bor, Nemikortani es Boronkologiai Klinika" are 6 trials for "All" genders.

Currently, there are NaN active trials in "SE AOK Bor, Nemikortani es Boronkologiai Klinika". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in SE AOK Bor, Nemikortani es Boronkologiai Klinika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SE AOK Bor, Nemikortani es Boronkologiai Klinika, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".